SCHEMBL7447969

SCHEMBL7447969

C[C@H](C(=O)O)N(C(=O)OC(C)(C)C)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.42
GAA P10253 1/20 0.42
CYP2C9 P11712 1/20 0.42
PKM P14618 1/20 0.42
CYP2C19 P33261 1/20 0.42
PDCD1 Q15116 1/20 0.42
CD274 Q9NZQ7 1/20 0.42
PTGS2 P35354 1/20 0.41
PAX8 Q06710 1/20 0.40
MAPT P10636 1/20 0.38
CTSS P25774 1/20 0.37
CTSK P43235 1/20 0.37
MMP2 P08253 2/20 0.36
MMP9 P14780 2/20 0.36
MMP8 P22894 2/20 0.36
MMP12 P39900 2/20 0.36
MMP13 P45452 2/20 0.36
MMP14 P50281 2/20 0.36
MMP16 P51512 2/20 0.36
MMP1 P03956 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1313198 1.00 CYP1A2 (0.42) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL9382586 0.91 SMN1; SMN2 (0.41) CYP1A2CYP2C9CYP2C19MMP13
SCHEMBL642839 0.91 SMN1; SMN2 (0.41) CYP1A2CYP2C9CYP2C19MMP13
SCHEMBL7308442 0.88 KMT2A (0.41) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL7446003 0.88 KMT2A (0.41) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL7439671 0.87 PDCD1 (0.38) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL8364820 0.84 MT-CO2 (0.45) CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL5846260 0.84 KMT2A (0.40) CTSSCTSKMMP13
SCHEMBL1208677 0.84 SMN1; SMN2 (0.37) CYP2C9CYP2C19CTSSCTSKMMP13
SCHEMBL10521312 0.84 NR1H2 (0.34) PAX8MMP2MMP9MMP13MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5354892-A Treating cardiovascular disorders; endopeptidase inhibitors; diuretics CIBA-GEIGY CORPORATION (US) 1994-10-11 US disclosed
EP-0555175-A1 Biaryl substituted 4-amino-butyric acid amides CIBA-GEIGY AG (CH) 1993-08-11 EP disclosed
US-5217996-A Endopeptidase inhibitors CIBA-GEIGY CORPORATION (US) 1993-06-08 US disclosed